Published in Behav Brain Res on January 08, 2001
Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain. BMC Neurosci (2008) 0.85
Factors producing a menopausal depressive-like state in mice following ovariectomy. Psychopharmacology (Berl) (2006) 0.84
Estrogen effects on the forced swim test differ in two outbred rat strains. Physiol Behav (2012) 0.81
Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats. Psychopharmacology (Berl) (2007) 0.79
Epi-inositol is ineffective in Porsolt Forced Swim Test model of depression. Neuropsychiatr Dis Treat (2005) 0.75
Antidepressant-like effect of Hoodia gordonii in a forced swimming test in mice: evidence for involvement of the monoaminergic system. Braz J Med Biol Res (2014) 0.75
In silico Analysis and Experimental Validation of Lignan Extracts from Kadsura longipedunculata for Potential 5-HT1AR Agonists. PLoS One (2015) 0.75
Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet (1996) 2.92
Genetic linkage between X-chromosome markers and bipolar affective illness. Nature (1987) 2.44
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl (2007) 2.12
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry (2002) 1.98
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res (2008) 1.84
Subtyping major depressive disorder. Psychother Psychosom (2010) 1.76
Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT). Mol Psychiatry (2000) 1.74
Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry (1998) 1.71
Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature (1988) 1.67
Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry (2005) 1.54
Computerized testing of neurocognitive function in euthymic bipolar patients compared to those with mild cognitive impairment and cognitively healthy controls. Psychother Psychosom (2011) 1.46
Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry (2006) 1.43
Absence of prion protein mutation in bipolar manic-depressive patients. Br J Psychiatry (1992) 1.36
Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders. Brain Res Bull (2008) 1.26
Trafficked female sex workers awaiting deportation: comparison with brothel workers. Arch Womens Ment Health (2004) 1.20
The mechanism of lithium action: state of the art, ten years later. Prog Neuropsychopharmacol Biol Psychiatry (2001) 1.20
How valuable are animal models in defining antidepressant activity? Hum Psychopharmacol (2001) 1.16
Ritual female genital surgery among Bedouin in Israel. Arch Sex Behav (1995) 1.15
The motivation and mental health of sex workers. J Sex Marital Ther (2002) 1.14
GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol (2002) 1.13
Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology (Berl) (1994) 1.12
Appropriate use of "knockout" mice as models of depression or models of testing the efficacy of antidepressants. Psychopharmacology (Berl) (2001) 1.12
Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results. Behav Pharmacol (2008) 1.12
Treatment of bipolar depression. N Engl J Med (2007) 1.11
Lithium's effect in forced-swim test is blood level dependent but not dependent on weight loss. Behav Pharmacol (2007) 1.09
Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry (2000) 1.07
Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Mol Psychiatry (1998) 1.05
Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex. Int J Neuropsychopharmacol (2005) 1.05
3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans. Neurosci Biobehav Rev (1999) 1.04
Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology (Berl) (1998) 1.04
Knockout mice in understanding the mechanism of action of lithium. Biochem Soc Trans (2009) 1.02
Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J Neural Transm (Vienna) (2004) 1.01
Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry (2012) 1.00
Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr Res (2001) 1.00
Omega 3 fatty acid treatment in autism. J Child Adolesc Psychopharmacol (2009) 1.00
Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function. Mol Psychiatry (2006) 1.00
The lessons of platelet monoamine oxidase. Psychol Med (1984) 0.99
Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial. Bipolar Disord (2010) 0.98
Influence of age on behavioural response in the light/dark paradigm. Physiol Behav (1999) 0.98
Ritual female genital surgery among Ethiopian Jews. Arch Sex Behav (1997) 0.98
The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.98
High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction. J Chromatogr B Biomed Sci Appl (2001) 0.97
Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of Novelty Seeking. Mol Psychiatry (1998) 0.96
Inositol treatment in psychiatry. Psychopharmacol Bull (1995) 0.96
Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol (2000) 0.96
Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). Depress Anxiety (2000) 0.96
Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry (1995) 0.95
TPQ in euthymic manic-depressive patients. J Psychiatr Res (1997) 0.95
Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm (Vienna) (1997) 0.95
Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study. Arch Gen Psychiatry (1979) 0.95
No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients. Schizophr Res (2008) 0.95
7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berl) (1997) 0.95
The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression. Brain Res (1995) 0.94
Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (1997) 0.94
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test. Eur J Pharmacol (1997) 0.94
Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.94
Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol Psychiatry (2006) 0.94
5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. J Neurochem (2001) 0.94
Lithium research: state of the art. Biol Psychiatry (1990) 0.94
Homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res (2004) 0.93
Dopamine D4 receptor (D4DR) and serotonin transporter promoter (5-HTTLPR) polymorphisms in the determination of temperament in 2-month-old infants. Mol Psychiatry (1999) 0.93
Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology (Berl) (1999) 0.93
The effects of inositol treatment in animal models of psychiatric disorders. J Affect Disord (2001) 0.92
The high affinity inositol transport system--implications for the pathophysiology and treatment of bipolar disorder. Bipolar Disord (2000) 0.92
The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. J Pharmacol Exp Ther (1980) 0.91
No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry (1997) 0.91
Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry (1997) 0.91
Lithium dosage and inositol levels. Br J Psychiatry (1994) 0.90
The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur J Pharmacol (1996) 0.90
Epi-inositol regulates expression of the yeast INO1 gene encoding inositol-1-P synthase. Mol Psychiatry (2002) 0.89
Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone. J Clin Psychiatry (2001) 0.89
Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat. Neuropharmacology (1987) 0.89
Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biol Psychiatry (1991) 0.89
Lithium inhibitable enzymes in postmortem brain of bipolar patients. J Psychiatr Res (2003) 0.89
A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav (1998) 0.89
Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder. J Neural Transm (Vienna) (2002) 0.88
Biogenic amine-related enzymes and personality variations in normals. Psychol Med (1977) 0.88
First report of mirtazapine-induced arthralgia. Eur Psychiatry (2001) 0.88
Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice. Psychopharmacology (Berl) (2001) 0.87
The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases. Curr Pharm Des (2011) 0.87
Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice. J Neurochem (2003) 0.87
The value of the reserpine test in psychopharmacology. Arzneimittelforschung (1983) 0.87
[Arthralgia associated with mirtazapine]. Therapie (2001) 0.87
Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am J Med Genet B Neuropsychiatr Genet (2003) 0.87
5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. Am J Med Genet (1997) 0.87
Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells. Innate Immun (2011) 0.86
Lithium preferentially inhibits adenylyl cyclase V and VII isoforms. Int J Neuropsychopharmacol (2008) 0.86
Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry (1995) 0.86
Right prefrontal TMS versus sham treatment of mania: a controlled study. Bipolar Disord (2003) 0.86
Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br J Pharmacol (2003) 0.86
The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus; a comparison with the yeast model. Brain Res Mol Brain Res (2003) 0.86
Behavioral evidence for the existence of two pools of cellular inositol. Eur Neuropsychopharmacol (1994) 0.86
Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression. Biol Psychiatry (1993) 0.86
The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test. Pharmacol Biochem Behav (2000) 0.85
SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior. Mol Genet Metab (2006) 0.85
Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice. Neuropsychopharmacology (2006) 0.85
Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry (1996) 0.85
High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.85
Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behav Brain Res (2006) 0.85
Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers. Eur Neuropsychopharmacol (1991) 0.85